Pediatric Urology and Regenerative Medicine Research Center, Section of Tissue Engineering and Stem Cells Therapy, Children's Medical Center, Pediatric Center of Excellence, Tehran University of Medical Sciences, No. 62, Dr. Gharib's Street, Keshavarz Boulevard, 1419433151, Tehran, Iran.
Adv Exp Med Biol. 2021;1345:47-59. doi: 10.1007/978-3-030-82735-9_5.
The field of tissue engineering and regenerative medicine is able to depict the mechanism of cardiac repair and development of cardiac function as well, in order to reveal findings to new therapeutic designs for clinical treatment. The foremost approach of this scientific field is the fabrication of scaffolds, which contain cells that can be used as cardiac grafts in the body, to have the preferred recovery. Cardiac tissue engineering has not been completely organized for routine clinical usages. Hence, engineering innovations hold promise to character research and treatment options in the years to come. Our group has extensive experience with regard to the structure of the heart, which makes us to our decision to continue with the preparation of heart, with the aim of developing a new ECM scaffold. Herein, we aim to assess the state-of-the-art fabrication methods, advances in decellularization and recellularization techniques. We also highlight the major achievements toward the production of a bioengineered heart obtained from decellularization and recellularization techniques.
组织工程和再生医学领域能够描绘心脏修复和心脏功能发展的机制,从而为临床治疗的新治疗设计揭示发现。该科学领域的首要方法是制造支架,其中包含可作为体内心脏移植物的细胞,以获得首选的恢复。心脏组织工程尚未完全组织用于常规临床应用。因此,工程创新有望在未来几年为特征研究和治疗选择提供帮助。我们的团队在心脏结构方面拥有丰富的经验,这使我们决定继续准备心脏,以开发新的 ECM 支架。在这里,我们旨在评估最先进的制造方法、脱细胞和再细胞化技术的进展。我们还强调了通过脱细胞和再细胞化技术生产生物工程心脏的主要成就。